Adamas Pharmaceuticals Inc. buy tamam
Start price
15.09.18
/
50%
€19.43
Target price
17.12.19
€10.00
Performance (%)
-82.19%
End price
17.12.19
€3.46
Summary
This prediction ended on 17.12.19 with a price of €3.46. The BUY prediction by tamam for Adamas Pharmaceuticals Inc. performed very badly with a performance of -82.19%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
| iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
| iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
| iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
Comments by tamam for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von klostergang zu
tamam stimmt am 13.09.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 42$ zu.
Überschrift: klostergang stimmt der Buy-Einschätzung von klostergang zu
Neueinstellung, weil vergessen zu verlängern!
Kursziel geändert auf 10,0
Stopped prediction by tamam for Adamas Pharmaceuticals Inc.
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.46
17.12.19
17.12.19
€6.00
04.11.21
04.11.21
103.76%
05.11.21
05.11.21
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.71
13.09.17
13.09.17
€37.88
13.09.18
13.09.18
8.97%
13.09.18
13.09.18